BesaGov

Contract 75D30123F00001

Glaxosmithkline, Llc · Department Of Health And Human Services · September 26, 2023

Firm Fixed PriceSole SourceNAICS 325411IDIQ Task Order

Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 26, 2023 for $14.81 million of work in medicinal and botanical manufacturing. Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ 75D30123D16461. The contract has been modified 61 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 26, 2026.

Obligated to date
$14.81M
$14,813,655
Current value
$1.57M
Potential value
$2.76M
if all options exercised
Modifications
61
Latest February 26, 2026

Contract details

PIID
75D30123F00001
Parent IDIQ
75D30123D16461
Award type
Delivery Order
Pricing
Firm Fixed Price
Competition
Not Competed
NAICS
325411 · Medicinal And Botanical Manufacturing
Product / service
Support- Management: Other
Place of performance
Durham, NC
First action
September 26, 2023
Latest action
February 26, 2026

Description

ADMIN MOD - BORROW / RETURN OF STOCKPILE VACCINE DOSES

Modification timeline

  • February 26, 2026
    Mod P00011 · Other Administrative Action
    $1.57M
  • January 29, 2026
    Mod P00010 · Other Administrative Action
    $1.57M
  • January 9, 2026
    Mod P00003 · Supplemental Agreement For Work Within Scope
    2023 D1-A05 WASTEWATER SURVEILLANCE, LTCAH AND NH FOR AR
    $1.05M
  • September 26, 2025
    Mod P00009 · Other Administrative Action
    $1.57M
  • September 25, 2025
    Mod P00005 · Exercise An Option
    DHQP SUPPORT SERVICES
    $2.88M
  • September 25, 2025
    Mod P00005 · Supplemental Agreement For Work Within Scope
    PROFESSIONAL SEVICES IN RWANDA
    $786.0K
  • September 24, 2025
    Mod P00003 · Exercise An Option
    2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
    $529.6K
  • September 24, 2025
    Mod P00002 · Exercise An Option
    2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
    $565.1K
  • September 23, 2025
    Mod P00004 · Exercise An Option
    DHQP SUPPORT SERVICES
    $2.74M
  • September 18, 2025
    Mod P00003 · Exercise An Option
    2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
    $636.4K
Sign up free to see all 62 modifications

Top contractors in NAICS 325411

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Amerisourcebergen Drug Corp25,623$1.30B
2Dms Pharmaceutical Group Inc1,544$2.26M
3Cardinal Health, Inc.575$1.06M
4Atlantic Diving Supply, Inc.155$949.6K
5Animal Health International, Inc.3$729.0K
6Johnson & Johnson Health Care Systems Inc.96$428.2K
7Cardinal Health 414, Llc1$328.3K
8Altitude Technologies Inc.146$273.0K
9Phoenix Textile Corporation136$171.4K
10Cardinal Health 108, Llc1$63.8K

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75D30123F00001?

Contract 75D30123F00001 is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on September 26, 2023 for $14.81 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 61 times since the base award.

Who won contract 75D30123F00001?

Glaxosmithkline, Llc won contract 75D30123F00001 from Department Of Health And Human Services.

How much is contract 75D30123F00001 worth?

Contract 75D30123F00001 has obligated $14.81 million to date.